Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lanying Du

Showing results (51-60 of 182) with videos related to

Pageof 19
Sort By:
Microbes and Infection|May 22, 2020
From SARS-CoV to SARS-CoV-2: safety and broad-spectrum are important for coronavirus vaccine developmentCuiqing Ma, Shan Su, Jiachao Wang, et al.
Vaccines|November 14, 2019
Effects of Adjuvants on the Immunogenicity and Efficacy of a Zika Virus Envelope Domain III Subunit VaccineXinyi Wang, Wanbo Tai, Xiaolu Zhang, et al.
Microbes and Infection|December 6, 2014
Adenovirus-based vaccines against avian-origin H5N1 influenza virusesBiao He, Bo-jian Zheng, Qian Wang, et al.
Microbes and Infection|December 23, 2014
Advancements in the development of subunit influenza vaccinesNaru Zhang, Bo-Jian Zheng, Lu Lu, et al.
Viruses|January 25, 2013
Approaches for identification of HIV-1 entry inhibitors targeting gp41 pocketFei Yu, Lu Lu, Lanying Du, et al.
Iscience|December 6, 2022
mRNA vaccines elicit potent neutralization against multiple SARS-CoV-2 omicron subvariants and other variants of concernGang Wang, Juan Shi, Abhishek K Verma, et al.
Nature Reviews. Microbiology|February 10, 2009
The spike protein of SARS-CoV--a target for vaccine and therapeutic developmentLanying Du, Yuxian He, Yusen Zhou, et al.
Iscience|October 12, 2023
Glycosylated Delta-receptor-binding domain mucosal vaccine elicits broadly neutralizing antibodies with protection against SARS-CoV-2 challengeXiaoqing Guan, Abhishek K Verma, Gang Wang, et al.
Cells|December 10, 2025
MERS-CoV RBD-mRNA Presents Better Immunogenicity and Protection than the Spike-mRNAQian Liu, Abhishek K Verma, Xiaoqing Guan, et al.
Vaccines|June 27, 2024
A Unique mRNA Vaccine Elicits Protective Efficacy against the SARS-CoV-2 Omicron Variant and SARS-CoVXiaoqing Guan, Abhishek K Verma, Gang Wang, et al.
Pageof 19

Showing results (51-60 of 182) with videos related to

Sort By:
Pageof 19
Microbes and Infection|May 22, 2020
From SARS-CoV to SARS-CoV-2: safety and broad-spectrum are important for coronavirus vaccine developmentCuiqing Ma, Shan Su, Jiachao Wang, et al.
Vaccines|November 14, 2019
Effects of Adjuvants on the Immunogenicity and Efficacy of a Zika Virus Envelope Domain III Subunit VaccineXinyi Wang, Wanbo Tai, Xiaolu Zhang, et al.
Microbes and Infection|December 6, 2014
Adenovirus-based vaccines against avian-origin H5N1 influenza virusesBiao He, Bo-jian Zheng, Qian Wang, et al.
Microbes and Infection|December 23, 2014
Advancements in the development of subunit influenza vaccinesNaru Zhang, Bo-Jian Zheng, Lu Lu, et al.
Viruses|January 25, 2013
Approaches for identification of HIV-1 entry inhibitors targeting gp41 pocketFei Yu, Lu Lu, Lanying Du, et al.
Iscience|December 6, 2022
mRNA vaccines elicit potent neutralization against multiple SARS-CoV-2 omicron subvariants and other variants of concernGang Wang, Juan Shi, Abhishek K Verma, et al.
Nature Reviews. Microbiology|February 10, 2009
The spike protein of SARS-CoV--a target for vaccine and therapeutic developmentLanying Du, Yuxian He, Yusen Zhou, et al.
Iscience|October 12, 2023
Glycosylated Delta-receptor-binding domain mucosal vaccine elicits broadly neutralizing antibodies with protection against SARS-CoV-2 challengeXiaoqing Guan, Abhishek K Verma, Gang Wang, et al.
Cells|December 10, 2025
MERS-CoV RBD-mRNA Presents Better Immunogenicity and Protection than the Spike-mRNAQian Liu, Abhishek K Verma, Xiaoqing Guan, et al.
Vaccines|June 27, 2024
A Unique mRNA Vaccine Elicits Protective Efficacy against the SARS-CoV-2 Omicron Variant and SARS-CoVXiaoqing Guan, Abhishek K Verma, Gang Wang, et al.
Pageof 19